FDAnews
www.fdanews.com/articles/73820-aeolus-gets-2-5-million-from-investors

AEOLUS GETS $2.5 MILLION FROM INVESTORS

June 28, 2005

Existing investors have pumped $2.5 million into Aeolus Pharmaceuticals, a Research Triangle Park drug development company. The investment comes about a week after Aeolus' board of directors hired California consulting firm McManus Financial Consultants, and its president, John McManus. A one-year employment agreement filed with the Securities and Exchange Commission promises John McManus a $75,000 bonus if Aeolus secures at least $5 million in investments.

The News & Observer (http://newsobserver.com/business/story/2542774p-8946727c.html)